Diabetes management technology developer Glooko announced today that it appointed Alfonso “Chito” Zulueta to its board of directors.
Zulueta joins Palo Alto, California-based Glooko’s board, having spent more than 30 years with Eli Lilly and Co., serving as a senior executive across an array of global business and commercial units.
Get the full story at our sister site, Drug Delivery Business News.